|
1
|
Ferlay J, Ervik M, Lam F, Colombet M, Mery
L, Pineros M, Znaor A, Soerjomataram I and Bray F: Global Cancer
Observatory: Cancer Today. International Agency for Research on
Cancer, Lyon, 2018.
|
|
2
|
Bosch FX, Burchell AN, Schiffman M,
Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK and
Muñoz N: Epidemiology and natural history of human papillomavirus
infections and type-specific implications in cervical neoplasia.
Vaccine. 26 (Suppl 10):K1–K16. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
zur Hausen H: Papillomaviruses in the
causation of human cancers - a brief historical account. Virology.
384:260–265. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Clifford GM, Smith JS, Plummer M, Muñoz N
and Franceschi S: Human papillomavirus types in invasive cervical
cancer worldwide: A meta-analysis. Br J Cancer. 88:63–73.
2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Egawa N and Doorbar J: The low-risk
papillomaviruses. Virus Res. 231:119–127. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Muñoz N, Bosch FX, de Sanjosé S, Herrero
R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ:
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group. Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tulay P and Serakinci N: The role of human
papillomaviruses in cancer progression. J Cancer Metastasis Treat.
2:201–213. 2016.
|
|
9
|
zur Hausen H and de Villiers EM: Human
papillomaviruses. Annu Rev Microbiol. 48:427–447. 1994.
|
|
10
|
Havre PA, Yuan J, Hedrick L, Cho KR and
Glazer PM: p53 inactivation by HPV16 E6 results in increased
mutagenesis in human cells. Cancer Res. 55:4420–4424.
1995.PubMed/NCBI
|
|
11
|
Pim D, Massimi P and Banks L:
Alternatively spliced HPV-18 E6* protein inhibits E6 mediated
degradation of p53 and suppresses transformed cell growth.
Oncogene. 15:257–264. 1997.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Caldeira S, Dong W and Tommasino M:
Analysis of E7/Rb associations. Methods Mol Med. 119:363–379.
2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu EW, Clemens KE, Heck DV and Münger K:
The human papillomavirus E7 oncoprotein and the cellular
transcription factor E2F bind to separate sites on the
retinoblastoma tumor suppressor protein. J Virol. 67:2402–2407.
1993.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Collins AS, Nakahara T, Do A and Lambert
PF: Interactions with pocket proteins contribute to the role of
human papillomavirus type 16 E7 in the papillomavirus life cycle. J
Virol. 79:14769–14780. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Slebos RJ, Lee MH, Plunkett BS, Kessis TD,
Williams BO, Jacks T, Hedrick L, Kastan MB and Cho KR:
p53-dependent G1 arrest involves pRB-related proteins and is
disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl
Acad Sci USA. 91:5320–5324. 1994.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Scheffner M, Werness BA, Huibregtse JM,
Levine AJ and Howley PM: The E6 oncoprotein encoded by human
papillomavirus types 16 and 18 promotes the degradation of p53.
Cell. 63:1129–1136. 1990.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Villa LL: Human papillomaviruses and
cervical cancer. Adv Cancer Res. 71:321–341. 1997.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Schwarz E, Freese UK, Gissmann L, Mayer W,
Roggenbuck B, Stremlau A and zur Hausen H: Structure and
transcription of human papillomavirus sequences in cervical
carcinoma cells. Nature. 314:111–114. 1985.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Au Yeung CL, Tsang WP, Tsang TY, Co NN,
Yau PL and Kwok TT: HPV-16 E6 upregulation of DNMT1 through
repression of tumor suppressor p53. Oncol Rep. 24:1599–1604.
2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Burgers WA, Blanchon L, Pradhan S, de
Launoit Y, Kouzarides T and Fuks F: Viral oncoproteins target the
DNA methyltransferases. Oncogene. 26:1650–1655. 2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Sen P, Ganguly P and Ganguly N: Modulation
of DNA methylation by human papillomavirus E6 and E7 oncoproteins
in cervical cancer. Oncol Lett. 15:11–22. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li L, Xu C, Long J, Shen D, Zhou W, Zhou
Q, Yang J and Jiang M: E6 and E7 gene silencing results in
decreased methylation of tumor suppressor genes and induces
phenotype transformation of human cervical carcinoma cell lines.
Oncotarget. 6:23930–23943. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chalertpet K, Pakdeechaidan W, Patel V,
Mutirangura A and Yanatatsaneejit P: Human papillomavirus type 16
E7 oncoprotein mediates CCNA1 promoter methylation. Cancer Sci.
106:1333–1340. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yanatatsaneejit P, Chalertpet K,
Sukbhattee J, Nuchcharoen I, Phumcharoen P and Mutirangura A:
Promoter methylation of tumor suppressor genes induced by human
papillomavirus in cervical cancer. Oncol Lett. 20:955–961.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Na Rangsee N, Yanatatsaneejit P, Pisitkun
T, Somparn P, Jintaridth P and Topanurak S: Host proteome linked to
HPV E7-mediated specific gene hypermethylation in cancer pathways.
Infect Agent Cancer. 15(7)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Śliwa A, Kubiczak M, Szczerba A, Walkowiak
G, Nowak-Markwitz E, Burczyńska B, Butler S, Iles R, Białas P and
Jankowska A: Regulation of human chorionic gonadotropin beta
subunit expression in ovarian cancer. BMC Cancer.
19(746)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bellet D, Lazar V, Bièche I, Paradis V,
Giovangrandi Y, Paterlini P, Lidereau R, Bedossa P, Bidart JM and
Vidaud M: Malignant transformation of nontrophoblastic cells is
associated with the expression of chorionic gonadotropin beta genes
normally transcribed in trophoblastic cells. Cancer Res.
57:516–523. 1997.PubMed/NCBI
|
|
29
|
Sohr S and Engeland K: The tumor
suppressor p53 induces expression of the pregnancy-supporting human
chorionic gonadotropin (hCG) CGB7 gene. Cell Cycle. 10:3758–3767.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gong J, Li Y, Liu CJ, Xiang Y, Li C, Ye Y,
Zhang Z, Hawke DH, Park PK, Diao L, et al: A Pan-cancer analysis of
the expression and clinical relevance of small nucleolar RNAs in
human cancer. Cell Rep. 21:1968–1981. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Christman JK: 5-Azacytidine and
5-aza-2'-deoxycytidine as inhibitors of DNA methylation:
Mechanistic studies and their implications for cancer therapy.
Oncogene. 21:5483–5495. 2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Stresemann C and Lyko F: Modes of action
of the DNA methyltransferase inhibitors azacytidine and decitabine.
Int J Cancer. 123:8–13. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Glover AB and Leyland-Jones B:
Biochemistry of azacitidine: A review. Cancer Treat Rep.
71:959–964. 1987.PubMed/NCBI
|
|
34
|
Miranda TB and Jones PA: DNA methylation:
The nuts and bolts of repression. J Cell Physiol. 213:384–390.
2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Müller A and Florek M:
5-Azacytidine/Azacitidine. Recent Results Cancer Res. 184:159–170.
2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lande-Diner L, Zhang J, Ben-Porath I,
Amariglio N, Keshet I, Hecht M, Azuara V, Fisher AG, Rechavi G and
Cedar H: Role of DNA methylation in stable gene repression. J Biol
Chem. 282:12194–12200. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cheng JC, Matsen CB, Gonzales FA, Ye W,
Greer S, Marquez VE, Jones PA and Selker EU: Inhibition of DNA
methylation and reactivation of silenced genes by zebularine. J
Natl Cancer Inst. 95:399–409. 2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ferguson AT, Lapidus RG, Baylin SB and
Davidson NE: Demethylation of the estrogen receptor gene in
estrogen receptor-negative breast cancer cells can reactivate
estrogen receptor gene expression. Cancer Res. 55:2279–2283.
1995.PubMed/NCBI
|
|
39
|
Karpf AR and Jones DA: Reactivating the
expression of methylation silenced genes in human cancer. Oncogene.
21:5496–5503. 2002.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Baylin SB: DNA methylation and gene
silencing in cancer. Nat Clin Pract Oncol. 2 (Suppl 1):S4–S11.
2005.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Sova P, Feng Q, Geiss G, Wood T, Strauss
R, Rudolf V, Lieber A and Kiviat N: Discovery of novel methylation
biomarkers in cervical carcinoma by global demethylation and
microarray analysis. Cancer Epidemiol Biomarkers Prev. 15:114–123.
2006.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Biktasova A, Hajek M, Sewell A, Gary C,
Bellinger G, Deshpande HA, Bhatia A, Burtness B, Judson B, Mehra S,
et al: Demethylation therapy as a targeted treatment for human
papillomavirus-associated head and neck cancer. Clin Cancer Res.
23:7276–7287. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Messeguer X, Escudero R, Farré D, Núñez O,
Martínez J and Albà MM: PROMO: Detection of known transcription
regulatory elements using species-tailored searches.
Bioinformatics. 18:333–334. 2002.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Farré D, Roset R, Huerta M, Adsuara JE,
Roselló L, Albà MM and Messeguer X: Identification of patterns in
biological sequences at the ALGGEN server: PROMO and MALGEN.
Nucleic Acids Res. 31:3651–3653. 2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Fornes O, Castro-Mondragon JA, Khan A, van
der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M,
Baranašić D, et al: JASPAR 2020: Update of the open-access database
of transcription factor binding profiles. Nucleic Acids Res.
48:D87–D92. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Maniatis T, Fritsch EF and Sambrook J:
Isolation of DNA from mammalian cells. In: Molecular Cloning. A
Laboratory Manual. Nolan C (ed). Cold Spring Harbor, New York, NY,
9.16-9.23, 1982.
|
|
47
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wong J, Sia YY, Misso NL, Aggarwal S, Ng A
and Bhoola KD: Effects of the demethylating agent, 5-azacytidine,
on expression of the kallikrein-kinin genes in carcinoma cells of
the lung and pleura. Patholog Res Int. 2011(167046)2011.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Abdulhaq H and Rossetti JM: The role of
azacitidine in the treatment of myelodysplastic syndromes. Expert
Opin Investig Drugs. 16:1967–1975. 2007.PubMed/NCBI View Article : Google Scholar
|
